Ubs Group Ag Eucrates Biomedical Acquisition Corp. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
SELL
$9.87 - $9.99 $4,283 - $4,335
-434 Reduced 11.08%
3,483 $34,000
Q3 2022

Nov 10, 2022
BUY
$9.89 - $10.0 $17,030 - $17,220
1,722 Added 78.45%
3,917 $39,000
Q2 2022

Aug 10, 2022
SELL
$9.85 - $9.91 $3,319 - $3,339
-337 Reduced 13.31%
2,195 $22,000
Q1 2022

May 16, 2022
BUY
$9.76 - $9.85 $20,896 - $21,088
2,141 Added 547.57%
2,532 $25,000
Q4 2021

Feb 14, 2022
SELL
$9.75 - $9.85 $20,562 - $20,773
-2,109 Reduced 84.36%
391 $4,000
Q3 2021

Nov 15, 2021
SELL
$9.65 - $9.99 $12,535 - $12,977
-1,299 Reduced 34.19%
2,500 $24,000
Q2 2021

Aug 13, 2021
SELL
$9.69 - $10.22 $1,501 - $1,584
-155 Reduced 3.92%
3,799 $37,000
Q1 2021

May 12, 2021
BUY
$9.79 - $10.64 $38,709 - $42,070
3,954 New
3,954 $39,000

About Eucrates Biomedical Acquisition Corp.

EUCR Quotes by TradingView
  • Ticker EUCR
  • Exchange
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,459,100
More about EUCR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email